ReviewPathogens (Basel, Switzerland)2020
Pathogenomics and Management of
Review in Pathogens (Basel, Switzerland), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 54 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
54 citing papers in PubMed, 129 citations in OpenAlex.
- Antifungal activity of Burkholderia sensu lato metabolites against coffee phytopathogens: evidence of chemical diversity.World journal of microbiology & biotechnology · 2026Article
- Whole genome sequencing and annotation of a non-pathogenic Fusarium brachygibbosum TZ1MST22 strain isolated from Medicago sativa in Southern Tunisian oases.Functional & integrative genomics · 2026Article
- An Economical Bioprocess for Lipopeptide Production From Bacillus subtilis.MicrobiologyOpen · 2026Article
- Myco-synthesized copper oxide nanoparticles as a sustainable bionanofungicide for managing Fusarium falciforme and enhancing potato productivity.Scientific reports · 2026Article
- First report of Fusarium solani species complex infection on mandarin and maltese in Tunisia and semi-quantitative analysis of mycotoxins production in vitro.BMC microbiology · 2026Article
- The potentiality of nodule-inhabiting fungi to control the growth of Fusarium oxysporum.World journal of microbiology & biotechnology · 2026Article
- Arabinoxylan and pectin features differentiate maize inbred lines with contrasting Fusarium stalk rot resistance.Frontiers in plant science · 2026Article
- Antifungal Effects and Mechanism of Dihydrochelerythrine AgainstMicroorganisms · 2025Article
- From Morphology to Multi-Omics: A New Age of Fusarium Research.Pathogens (Basel, Switzerland) · 2025Review
- Review
- A New Root and Trunk Rot Disease of Grapevine Plantlets Caused byJournal of fungi (Basel, Switzerland) · 2025Article
- Algae and Cyanobacteria Fatty Acids and Bioactive Metabolites: Natural Antifungal Alternative AgainstMicroorganisms · 2025Review
- Biocontrol ofPlants (Basel, Switzerland) · 2025Article
- Fungicide resistance in Fusarium species: exploring environmental impacts and sustainable management strategies.Archives of microbiology · 2025Review
- Identification of a novel hypovirulence-inducing ourmia-like mycovirus fromFrontiers in microbiology · 2025Article
- Synergistic effects ofFrontiers in microbiology · 2025Article
- Fusarium Genome Sequencing and Assembly.Methods in molecular biology (Clifton, N.J.) · 2025Article
- The Importance of Agricultural Fungi on Human and Animal Health: Case Studies from Grains.Current topics in microbiology and immunology · 2025Review
- FgGET3, an ATPase of the GET Pathway, Is Important for the Development and Virulence ofInternational journal of molecular sciences · 2024Article
- Harnessing RNA interference for the control of Fusarium species: A critical review.Molecular plant pathology · 2024Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author at 1 institution in 1 country.
Funding
Abstract
There is an urgency to supplant the heavy reliance on chemical control of
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.